Form 4: Encompass Health Director Carmichael Acquires Stock

Encompass Health Corp. reports a Form 4 filing detailing a stock acquisition by Director Greg D. Carmichael.

Summary

• Director Greg D. Carmichael acquired 1,634 shares of Encompass Health Corp. common stock.
• The acquisition occurred on May 7, 2026, with a transaction code 'A' indicating acquisition.
• The shares were acquired at a price of $0, suggesting an award or grant.
• Following this transaction, Carmichael beneficially owns 20,320 shares of Encompass Health common stock.
• This transaction is related to an annual grant of restricted stock units (RSUs) under the Corporation's 2025 Omnibus Performance Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine stock grant to a director rather than a significant market-moving event.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 1,634 shares at $0 price indicates a stock grant, likely part of executive compensation and incentive alignment.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Management Comments

• Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

Industry Context

StockSavvy.ai notes that insider stock grants, such as the RSUs awarded to Director Carmichael, are common in the healthcare services industry as a tool for executive compensation and to align management's interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of insider confidence, though the RSU nature suggests it's part of compensation rather than an open market purchase.

Key Dates

Keywords

Encompass Health Corp, EHC, Form 4, SEC Filing, Director, Stock Acquisition, Restricted Stock Units, Omnibus Performance Incentive Plan, Beneficial Ownership